Export 9 results:
Author Title [ Type(Desc)] Year
Filters: Author is Edwards, KM  [Clear All Filters]
Journal Article
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., Creech, C. B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children, Pediatr Infect Dis J, vol. 33, pp. 865-871, 2014.
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K., Graham, I. L., Noah, D. L., He, F., and Hill, H., Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults, J Infec Dis, vol. 197, pp. 667-675, 2008.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., Creech, C. B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. R., Wolff, M., and Edwards, K. M., Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women, J Infect Dis, vol. 204, pp. 854-863, 2011.
R. B. Belshe, Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P., Dolor, R. J., Woods, C. W., Walter, E. B., Chen, W. H., Turley, C., Edwards, K. M., Creech, C. B., Hill, H., and Bellamy, A. R., Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine with MF59 Adjuvant: A Randomized Clinical Trial, JAMA, vol. 312, pp. 1420-1428, 2014.
S. T. Callahan, Wolff, M., Hill, H. R., Edwards, K. M., Vaccine, N. I. A. I. D., and Group, T. Evaluation, Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults, J Infect Dis, vol. 210, pp. 1270-1274, 2014.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009, Vaccine, vol. 13, pp. 4240-4248, 2012.
C. B. Creech, Dekker, C. L., Ho, D., Phillips, S., Mackey, S., Murray-Krezan, C., M Pau, G., Hendriks, J., Brown, V., Dally, L. G., Versteege, I., and Edwards, K. M., Randomized, Placebo-Controlled Trial to Assess the Safety and Immunogenicity of an Adenovirus type 35-Based Circumsporozoite Malaria Vaccine in Healthy Adults, Hum Vaccin Immunother, vol. 9, pp. 2548-2557, 2013.
L. P. Stadler, Bernstein, D., Callahan, S. T., Turley, C. B., Munoz, F. M., Ferreira, J., Acharya, M., Simone, G. A. Gorgone, Patel, S. M., Edwards, K. M., and Rosenthal, S. L., Seroprevalence and Risk Factors for Cytomegalovirus Infections in Adolescent Females, J Ped Infec Dis, vol. 2, pp. 7-14, 2013.
T. Talbot, Stapleton, J. T., Brady, R. C., Winokur, P. L., Bernstein, D. I., Germanson, T., Yoder, S., Rock, M. T., Crowe, J. E., and Edwards, K. M., Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine, J Amer Med Assn, vol. 292, pp. 1205-1212, 2004.